Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: A multiple criteria decision analysis

J. C. Hsu, D. H. Tang, C. Y. Lu

研究成果: 雜誌貢獻文章同行評審

8 引文 斯高帕斯(Scopus)

指紋

深入研究「Risk-benefit assessment of oral phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction: A multiple criteria decision analysis」主題。共同形成了獨特的指紋。

Medicine & Life Sciences